Nicholas G. Evans, PhD, is a co-principal at Rogue Bioethics, a boutique consulting firm in Massachusetts. He also conducts research on public health ethics and global health security.
The benefits of ending a trial early must be weighed carefully against the risks
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.